https://pittplusme.org/study/1500
Study of Obeticholic Acid in Patients with Primary Biliary Cholangitis and Hepatic Impairment
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Do you have primary biliary cholangitis (also known as primary biliary cirrhosis or PBC)? If so, you may be eligible to participate in a study to help researchers find out how the study drug, Obeticholic Acid, is absorbed, distributed, and excreted from the body. Involves at least 19 visits over 3 years. Compensation is provided.
IRB: SSU00070765
- Intercept Pharmaceuticals, Inc. – 747-401, A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients with Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment (Pro00024186)
AGE:
18 and up
DURATION:
3 years
VISITS:
19 visits
LOCATION:
UPMC Montefiore Hospital - Oakland
COMPENSATION:
$50 & a parking voucher for each completed visit
SHARE STUDY
